Splenic index score as a predictor of outcomes in metastatic non small cell lung cancer patients treated with immune checkpoint inhibitors

Abstract Introduction Immune checkpoint inhibitors (ICIs) targeting PD-1 and PD-L1 have emerged as promising treatments for advanced NSCLC patients without actionable mutations. However, predicting treatment response remains challenging, especially in second-line settings. Although PD-L1 is the only...

Cur síos iomlán

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Volkan Aslan, Atiye Cenay Karabörk Kılıç, Nigar Rustamova Cennet, Talha alperen Yücel, Bediz kurt inci, Fatih gürler, Ahmet Özet, Nuriye Özdemir, Huseyin Koray Kilic, Ozan Yazıcı
Formáid:	Artigo
Teanga:	Inglês
Foilsithe / Cruthaithe:	Nature Portfolio 2025-05-01
Sraith:	Scientific Reports
Ábhair:	Immune checkpoint inhibitor Splenic volume mNSCLC Systemic inflammation NLR
Rochtain ar líne:	https://doi.org/10.1038/s41598-025-00708-w
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Splenic index score as a predictor of outcomes in metastatic non small cell lung cancer patients treated with immune checkpoint inhibitors

Míreanna comhchosúla